Angiotensin receptor blockers – eprosartan

Last updated on August 26, 2024

Generic name 

eprosartan, including in combination with hydrochlorothiazide

Strength

600 mg, 600 mg/12.5 mg

Form

tablet

Special Authority criteria

Approval period

Person identified as experiencing intractable cough or angioedema on Angiotensin Converting Enzyme Inhibitor (ACE-I)

AND

Failure on optimal doses of, or intolerance to, ALL reference drugs: candesartan, losartan, telmisartan AND valsartan

Indefinite

Practitioner exemptions

  • None

Special notes

  • Individuals requiring a diuretic combination product must satisfy the same criteria
  • Eprosartan 300mg and 400mg dosages are not PharmaCare benefits

Special Authority request form(s)